AJP - Regu Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 275: R426-R438, 1998;
0363-6119/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Su, P.
Right arrow Articles by Kroetz, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Su, P.
Right arrow Articles by Kroetz, D. L.
Vol. 275, Issue 2, R426-R438, August 1998

Inhibition of renal arachidonic acid omega -hydroxylase activity with ABT reduces blood pressure in the SHR

Ping Su1, K. Maya Kaushal1, and Deanna L. Kroetz1,2

1 Departments of Biopharmaceutical Sciences and Pharmaceutical Chemistry, School of Pharmacy, and the 2 Liver Center, School of Medicine, University of California San Francisco, San Francisco, California 94143

The mechanism-based cytochrome P-450 (CYP) inhibitor 1-aminobenzotriazole (ABT) was characterized as an inhibitor of renal arachidonic acid metabolism and administered to spontaneously hypertensive rats (SHRs) to determine the effect of reduced eicosanoid production on mean arterial pressure (MAP). A single intraperitoneal dose of ABT to Sprague-Dawley rats caused a dose-dependent loss of renal CYP content, arachidonic acid metabolism, and CYP4A protein. In the cortex and outer medulla, ABT showed a high degree of selectivity for the CYP4A enzymes, reflected by the potent inhibition of 19- and 20-hydroxyeicosatetraenoic acid (19- and 20-HETE) formation. A 50 mg/kg dose of ABT reduced cortical 20-HETE formation to 16.1 ± 0.82% of control and outer medullary 20-HETE formation to 23.8 ± 0.45% of control. In contrast, there was no inhibition of renal epoxygenase activity at this dose. Renal CYP content, arachidonic acid omega - and (omega -1)-hydroxylase activity, and CYP4A protein levels gradually return to control levels by 72 h after a single dose of ABT. Cortical 20-HETE formation recovered from 17.9 ± 3.15% of control at 6 h to 84.8 ± 4.67% of control at 72 h after ABT administration. A single injection of ABT to 7-wk-old SHRs caused an acute reduction in MAP, which remained suppressed for at least 12 h. The effect was maximal within 4 h and averaged 17-23 mmHg during the 4- to 12-h period after administration. 20-HETE formation was inhibited 85% in the cortex and 70-80% in the outer medulla during the period when MAP was reduced. A structurally related ABT analog 1-hydroxybenzotriazole had no effect on blood pressure or renal arachidonic acid metabolism. These results identify ABT as a selective inhibitor of renal CYP4A activity and provide further support for a role for 20-HETE in the regulation of blood pressure.

cytochrome P-450 4A; 20-hydroxyeicosatetraenoic acid; renal eicosanoids


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
K. Inoue, K. Sodhi, N. Puri, K. H. Gotlinger, J. Cao, R. Rezzani, J. R. Falck, N. G. Abraham, and M. Laniado-Schwartzman
Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE
Am J Physiol Renal Physiol, October 1, 2009; 297(4): F875 - F884.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. M. Dunn, M. Renic, A. K. Flasch, D. R. Harder, J. Falck, and R. J. Roman
Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2455 - H2465.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
E. M. Awumey, S. K. Hill, D. I. Diz, and R. D. Bukoski
Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2+-induced relaxation of rat mesenteric arteries
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2363 - H2370.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
C. Kirchheimer, C. F. Mendez, A. Acquier, and S. Nowicki
Role of 20-HETE in D1/D2 dopamine receptor synergism resulting in the inhibition of Na+-K+-ATPase activity in the proximal tubule
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1435 - F1442.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
N. Miyata, T. Seki, Y. Tanaka, T. Omura, K. Taniguchi, M. Doi, K. Bandou, S. Kametani, M. Sato, S. Okuyama, et al.
Beneficial Effects of a New 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor, TS-011 [N-(3-Chloro-4-morpholin-4-yl) Phenyl-N'-hydroxyimido Formamide], on Hemorrhagic and Ischemic Stroke
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 77 - 85.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. A. Dos Santos, A. J. Dahly-Vernon, K. M. Hoagland, and R. J. Roman
Inhibition of the formation of EETs and 20-HETE with 1-aminobenzotriazole attenuates pressure natriuresis
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R58 - R68.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
K. M. Hoagland, A. K. Flasch, and R. J. Roman
Inhibitors of 20-HETE Formation Promote Salt-Sensitive Hypertension in Rats
Hypertension, October 1, 2003; 42(4): 669 - 673.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
H. He, T. Podymow, J. Zimpelmann, and K. D. Burns
NO inhibits Na+-K+-2Cl- cotransport via a cytochrome P-450-dependent pathway in renal epithelial cells (MMDD1)
Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1235 - F1244.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
O. Skott
Androgen-induced activation of 20-HETE production may contribute to gender differences in blood pressure regulation
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R1053 - R1054.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Nakagawa, J. S. Marji, M. L. Schwartzman, M. R. Waterman, and J. H. Capdevila
Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R1055 - R1062.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
D. E. Stec, A. Flasch, R. J. Roman, and J. A. White
Distribution of cytochrome P-450 4A and 4F isoforms along the nephron in mice
Am J Physiol Renal Physiol, January 1, 2003; 284(1): F95 - F102.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. Xu, W. O. Straub, W. Pak, P. Su, K. G. Maier, M. Yu, R. J. Roman, P. R. Ortiz De Montellano, and D. L. Kroetz
Antihypertensive effect of mechanism-based inhibition of renal arachidonic acid omega -hydroxylase activity
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R710 - R720.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Alonso-Galicia, K. G. Maier, A. S. Greene, A. W. Cowley Jr., and R. J. Roman
Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R60 - R68.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M.-H. Wang, B. A. Zand, A. Nasjletti, and M. Laniado-Schwartzman
Renal 20-hydroxyeicosatetraenoic acid synthesis during pregnancy
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R383 - R389.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
R. J. Roman
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Physiol Rev, January 1, 2002; 82(1): 131 - 185.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
F. Zhang, M.-H. Wang, U.M. Krishna, J. R. Falck, M. Laniado-Schwartzman, and A. Nasjletti
Modulation by 20-HETE of Phenylephrine-Induced Mesenteric Artery Contraction in Spontaneously Hypertensive and Wistar-Kyoto Rats
Hypertension, December 1, 2001; 38(6): 1311 - 1315.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
I. Fleming
Cytochrome P450 and Vascular Homeostasis
Circ. Res., October 26, 2001; 89(9): 753 - 762.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
B. Lopez, C. Moreno, M. G. Salom, R. J. Roman, and F. J. Fenoy
Role of guanylyl cyclase and cytochrome P-450 on renal response to nitric oxide
Am J Physiol Renal Physiol, September 1, 2001; 281(3): F420 - F427.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
S. I. Pomposiello, M. A. Carroll, J. R. Falck, and J. C. McGiff
Epoxyeicosatrienoic Acid-Mediated Renal Vasodilation to Arachidonic Acid Is Enhanced in SHR
Hypertension, March 1, 2001; 37(3): 887 - 893.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
E. R. Jacobs and D. C. Zeldin
The lung HETEs (and EETs) up
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H1 - H10.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
Z. Yu, F. Xu, L. M. Huse, C. Morisseau, A. J. Draper, J. W. Newman, C. Parker, L. Graham, M. M. Engler, B. D. Hammock, et al.
Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids
Circ. Res., November 24, 2000; 87(11): 992 - 998.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. M. Muthalif, N. A. Karzoun, L. Gaber, Z. Khandekar, I. F. Benter, A. E. Saeed, J.-H. Parmentier, A. Estes, and K. U. Malik
Angiotensin II-Induced Hypertension : Contribution of Ras GTPase/Mitogen-Activated Protein Kinase and Cytochrome P450 Metabolites
Hypertension, October 1, 2000; 36(4): 604 - 609.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
H. Honeck, V. Gross, B. Erdmann, E. Kargel, R. Neunaber, A. F. Milia, W. Schneider, F. C. Luft, and W.-H. Schunck
Cytochrome P450-Dependent Renal Arachidonic Acid Metabolism in Desoxycorticosterone Acetate-Salt Hypertensive Mice
Hypertension, October 1, 2000; 36(4): 610 - 616.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. G. Maier, L. Henderson, J. Narayanan, M. Alonso-Galicia, J. R. Falck, and R. J. Roman
Fluorescent HPLC assay for 20-HETE and other P-450 metabolites of arachidonic acid
Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H863 - H871.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. M. Muthalif, I. F. Benter, Z. Khandekar, L. Gaber, A. Estes, S. Malik, J.-H. Parmentier, V. Manne, and K. U. Malik
Contribution of Ras GTPase/MAP Kinase and Cytochrome P450 Metabolites to Deoxycorticosterone-Salt-Induced Hypertension
Hypertension, January 1, 2000; 35(1): 457 - 463.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online